MAM
CRL icon

Martingale Asset Management’s Charles River Laboratories CRL Stock Holding History

Martingale Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,400
Closed -$274K – 800
2023
Q3 		$274K Hold
1,400
– – 0.01% 701
2023
Q2 		$294K Hold
1,400
– – 0.01% 699
2023
Q1 		$283K Sell
1,400
-395
-22% -$89.5K 0.01% 717
2022
Q4 		$391K Sell
1,795
-752
-30% -$164K 0.01% 672
2022
Q3 		$502K Sell
2,547
-53,981
-95% -$11.7M 0.01% 622
2022
Q2 		$12.1M Sell
56,528
-5,086
-8% -$1.24M 0.22% 129
2022
Q1 		$17.5M Sell
61,614
-6,586
-10% -$2.03M 0.26% 131
2021
Q4 		$25.7M Sell
68,200
-7,000
-9% -$2.72M 0.33% 116
2021
Q3 		$31M Sell
75,200
-16,013
-18% -$6.65M 0.41% 100
2021
Q2 		$33.7M Buy
91,213
+4,899
+6% +$1.64M 0.39% 99
2021
Q1 		$25M Buy
86,314
+4,370
+5% +$1.21M 0.29% 124
2020
Q4 		$20.5M Buy
81,944
+34,684
+73% +$8.26M 0.23% 133
2020
Q3 		$10.7M Buy
47,260
+39,655
+521% +$8.23M 0.13% 163
2020
Q2 		$1.33M Buy
7,605
+2,600
+52% +$415K 0.02% 659
2020
Q1 		$633K Buy
+5,005
New +$751K 0.01% 772

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Martingale Asset Management's CRL Position: Q4 2023 in Review

Martingale Asset Management sold out of Charles River Laboratories (CRL) in Q4 2023, closing a stake of 1,400 shares — an estimated $274K sold.

Martingale Asset Management first reported a position in CRL in Q1 2020 and held it in 15 quarters. The position peaked at $33.7M in Q2 2021. 634 funds tracked by Wall St. Rank hold CRL as of Q4 2023.

  • Martingale Asset Management reported no remaining Charles River Laboratories position as of Q4 2023 after selling out during the quarter.
  • Martingale Asset Management sold 1,400 Charles River Laboratories shares in Q4 2023, an estimated $274K.
  • Martingale Asset Management first reported a position in Charles River Laboratories in Q1 2020 and held it in 15 quarters.
  • Martingale Asset Management's Charles River Laboratories position peaked at $33.7M in Q2 2021.
  • 634 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2023.

Based on Martingale Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.